Search for
Menu
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Work with Us
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Work with Us
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Startup Resources
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Search for
Search Results
Search results for “clarametyx“
Clarametyx Biosciences Achieves Milestones in Investment, Clinical Trials, and Industry Recognition
Getting Funding, Press, Startup Buzz
By Ashley Baig
on
12/04/2024
Getting Funding, Press, Startup Buzz
Clarametyx Biosciences Achieves Milestones in Investment, Clinical Trials, and Industry Recognition
By Ashley Baig
on
12/04/2024
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Company News
05/04/2020
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC
05/31/2022
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
06/01/2023
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Funding News
01/05/2024
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Company News
10/24/2024
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Company News
11/19/2024
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Company News
01/07/2025
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Accelerating the Creation of Lifescience Companies in Ohio
Business, Getting Funding, Rev1 News
By Ryan Helon
on
09/19/2023
Business, Getting Funding, Rev1 News
Accelerating the Creation of Lifescience Companies in Ohio
By Ryan Helon
on
09/19/2023
1
2
Next »